The NeurologyLive® clinical focus page on sleep disorders provides information about the latest FDA actions, clinical guideline updates, clinical trial findings, and interviews with physicians on conditions such as obstructive sleep apnea, cataplexy, narcolepsy, insomnia, excessive daytime sleepiness, and more. The page features podcasts, videos, and news stories about the latest in clinical care for these sleep disorders.
September 1st 2025
Here's some of what is coming soon to NeurologyLive® this week.
Addressing the Neurologist Shortage and Increased Need for Neurologic Care
September 10th 2021Jennifer Majersik, MD, MS, division chief of vascular neurology at the University of Utah, discussed contributing factors to the neurologist shortage, as well as ongoing efforts to increase interest in the field.
New AASM Guideline, Improved Awareness of Sleep Disorders: Lynn Marie Trotti, MD, MSc
September 2nd 2021The professor of neurology at Emory University School of Medicine spoke on the potential for the new AASM hypersomnolence guideline to educate providers treating patients with sleep disorders.
New AASM Guideline for Treatment of Central Disorders of Hypersomnolence: Lynn Marie Trotti, MD
August 31st 2021The associate professor of neurology at Emory University School of Medicine provided an overview of the new guideline, which addresses narcolepsy, idiopathic hypersomnia, and Kleine-Levin syndrome.
Highlights of AASM Guideline for Treatment of Central Disorders of Hypersomnolence
August 24th 2021Coauthor and member of the American Academy of Sleep Medicine board of directors, Lynn Marie Trotti, MD, MSc, discussed key takeaways from the new guideline, which encompasses the first updates since 2007.
Filling a Critical Need for Idiopathic Hypersomnia With JZP-258 (Xywav)
August 19th 2021After the FDA approval for Jazz Pharmaceuticals' oxybates combination therapy, Robert Iannone, MD, MSCE, offered insight into the potential effects the drug may have on the clinical care of patients with idiopathic hypersomnia.